A 3-year-old boy from rural Maharashtra presents with recurrent episodes of hypoglycemia, lethargy, and hepatomegaly. His mother reports that symptoms worsen during fasting and improve after feeding. Laboratory investigations show: blood glucose 45 mg/dL (fasting), elevated liver transaminases (AST 120 U/L, ALT 110 U/L), normal ammonia levels, and markedly elevated serum free fatty acids (2.8 mmol/L). Urine organic acids show elevated dicarboxylic acids. A diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is suspected. Which of the following best explains the pathophysiology of hypoglycemia in this child?

Explanation

## Pathophysiology of Hypoglycemia in MCAD Deficiency ### Normal Fatty Acid Oxidation & Energy Coupling During fasting, fatty acids undergo β-oxidation in mitochondria to generate acetyl-CoA and NADH, which fuel ATP synthesis via oxidative phosphorylation. This ATP is essential for: - **Gluconeogenesis** (requires ATP at phosphoglycerate kinase and pyruvate carboxylase steps) - **Glucose-6-phosphatase** activity (final step of glucose release) - **Ion pumps** maintaining cellular homeostasis ### MCAD Deficiency Mechanism MCAD catalyzes the first dehydrogenation step in oxidation of medium-chain fatty acids (C6–C12). Loss of function causes: 1. **Impaired ATP generation** — medium-chain acyl-CoA substrates accumulate but cannot be oxidized efficiently 2. **Energy crisis in hepatocytes** — insufficient ATP for gluconeogenic enzymes 3. **Severe hypoglycemia** — especially during fasting when glucose production is critical ### Why Option 1 (CoA Sequestration) Is Incorrect While CoA depletion does occur, the PRIMARY problem is **lack of ATP**, not CoA availability. Gluconeogenesis can proceed with limited CoA if ATP is present. ### Why Option 3 (Malonyl-CoA Inhibition) Is Incorrect During fasting, malonyl-CoA levels are LOW (due to decreased acetyl-CoA carboxylase activity), so this is not the rate-limiting step. The block is at energy generation, not CPT-1 regulation. ### Why Option 4 (Transporter Inhibition) Is Incorrect Elevated FFAs do not inhibit glucose transporters. The problem is **hepatic glucose production**, not glucose uptake by peripheral tissues. **Key Point:** MCAD deficiency causes hypoglycemia during fasting because impaired β-oxidation reduces ATP availability for gluconeogenesis and glucose-6-phosphatase, not because of substrate accumulation or transporter blockade. **Clinical Pearl:** MCAD is the most common fatty acid oxidation disorder in Caucasians (1:10,000–1:20,000) but presents with **hypoketotic hypoglycemia** — FFAs are elevated but ketone production is paradoxically low because the block prevents complete oxidation to acetyl-CoA. **High-Yield:** The classic presentation is a previously well child with acute encephalopathy, hepatomegaly, and hypoglycemia triggered by fasting or viral illness. Dicarboxylic aciduria (from ω-oxidation of accumulated fatty acids) is a diagnostic clue. [cite:Lehninger Principles of Biochemistry 8e Ch 21]